{"id":"https://openalex.org/W4310163446","doi":"https://doi.org/10.1182/blood-2022-169930","title":"Survival Disparities Among People with HIV and Diffuse Large B-Cell Lymphoma in the Era of Novel Antiretroviral Therapy","display_name":"Survival Disparities Among People with HIV and Diffuse Large B-Cell Lymphoma in the Era of Novel Antiretroviral Therapy","publication_year":2022,"publication_date":"2022-11-15","ids":{"openalex":"https://openalex.org/W4310163446","doi":"https://doi.org/10.1182/blood-2022-169930"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2022-169930","doi":"https://doi.org/10.1182/blood-2022-169930","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2022-169930","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5068147019","display_name":"Daniel Arthur Ermann","orcid":"https://orcid.org/0000-0001-9233-294X","observed_orcids":["https://orcid.org/0000-0001-9233-294X"]},"institutions":[{"id":"https://openalex.org/I2801159745","display_name":"Huntsman Cancer Institute","ror":"https://ror.org/03v7tx966","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801159745","https://openalex.org/I4210148268"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel A. Ermann","raw_affiliation_strings":["1Department of Hematology/Oncology, Huntsman Cancer Institute, University of Utah, Omaha, NE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Hematology/Oncology, Huntsman Cancer Institute, University of Utah, Omaha, NE","institution_ids":["https://openalex.org/I2801159745"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059928593","display_name":"Victoria A. Vardell","orcid":"https://orcid.org/0000-0002-8117-1295","observed_orcids":["https://orcid.org/0000-0002-8117-1295"]},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Victoria A. Vardell","raw_affiliation_strings":["2Department of Internal Medicine, University of Utah, Salt Lake City, UT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Department of Internal Medicine, University of Utah, Salt Lake City, UT","institution_ids":["https://openalex.org/I223532165"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029632098","display_name":"Manasa Velagapudi","orcid":"https://orcid.org/0000-0002-4045-3261","observed_orcids":["https://orcid.org/0000-0002-4045-3261"]},"institutions":[{"id":"https://openalex.org/I114493937","display_name":"Creighton University","ror":"https://ror.org/05wf30g94","country_code":"US","type":"education","lineage":["https://openalex.org/I114493937"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Manasa Velagapudi","raw_affiliation_strings":["3Department of Infectious Disease, Creighton University, Omaha, NE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Department of Infectious Disease, Creighton University, Omaha, NE","institution_ids":["https://openalex.org/I114493937"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021580400","display_name":"Greer Burkholder","orcid":"https://orcid.org/0000-0001-7185-3025","observed_orcids":["https://orcid.org/0000-0001-7185-3025"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Greer Burkholder","raw_affiliation_strings":["4University of Alabama at Birmingham, Birmingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4University of Alabama at Birmingham, Birmingham, AL","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053468847","display_name":"Lindsey A. Fitzgerald","orcid":"https://orcid.org/0000-0001-5988-2878","observed_orcids":["https://orcid.org/0000-0001-5988-2878"]},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]},{"id":"https://openalex.org/I2801159745","display_name":"Huntsman Cancer Institute","ror":"https://ror.org/03v7tx966","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801159745","https://openalex.org/I4210148268"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lindsey A. Fitzgerald","raw_affiliation_strings":["5Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake CIty, UT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake CIty, UT","institution_ids":["https://openalex.org/I223532165","https://openalex.org/I2801159745"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004490449","display_name":"Mayur Subhash Narkhede","orcid":"https://orcid.org/0000-0002-2606-0533","observed_orcids":["https://orcid.org/0000-0002-2606-0533"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]},{"id":"https://openalex.org/I4390039250","display_name":"UAB Medicine","ror":"https://ror.org/036554539","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039250"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mayur Narkhede","raw_affiliation_strings":["6Division of Hematology/Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6Division of Hematology/Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL","institution_ids":["https://openalex.org/I32389192","https://openalex.org/I4390039250"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011348837","display_name":"Harsh Shah","orcid":"https://orcid.org/0000-0001-6054-5238","observed_orcids":["https://orcid.org/0000-0001-6054-5238"]},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]},{"id":"https://openalex.org/I2801159745","display_name":"Huntsman Cancer Institute","ror":"https://ror.org/03v7tx966","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801159745","https://openalex.org/I4210148268"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Harsh Shah","raw_affiliation_strings":["7Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"7Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT","institution_ids":["https://openalex.org/I223532165","https://openalex.org/I2801159745"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040342262","display_name":"Lauren Kelly Shea","orcid":"https://orcid.org/0000-0002-3584-9296","observed_orcids":["https://orcid.org/0000-0002-3584-9296"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lauren Shea","raw_affiliation_strings":["8University of Alabama At Birmingham, Birmingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"8University of Alabama At Birmingham, Birmingham, AL","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036762753","display_name":"Adam M. Spivak","orcid":"https://orcid.org/0000-0003-1815-7893","observed_orcids":["https://orcid.org/0000-0003-1815-7893"]},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Adam Spivak","raw_affiliation_strings":["9Department of Infectious Diseases, University of Utah, Salt Lake City, UT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"9Department of Infectious Diseases, University of Utah, Salt Lake City, UT","institution_ids":["https://openalex.org/I223532165"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031412066","display_name":"Deborah Marie Stephens","orcid":"https://orcid.org/0000-0001-9188-5008","observed_orcids":["https://orcid.org/0000-0001-9188-5008"]},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]},{"id":"https://openalex.org/I2801159745","display_name":"Huntsman Cancer Institute","ror":"https://ror.org/03v7tx966","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801159745","https://openalex.org/I4210148268"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Deborah M. Stephens","raw_affiliation_strings":["7Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"7Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT","institution_ids":["https://openalex.org/I223532165","https://openalex.org/I2801159745"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024273516","display_name":"Boyu Hu","orcid":"https://orcid.org/0000-0001-9848-9497","observed_orcids":["https://orcid.org/0000-0001-9848-9497"]},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]},{"id":"https://openalex.org/I2801159745","display_name":"Huntsman Cancer Institute","ror":"https://ror.org/03v7tx966","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801159745","https://openalex.org/I4210148268"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Boyu Hu","raw_affiliation_strings":["7Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"7Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT","institution_ids":["https://openalex.org/I223532165","https://openalex.org/I2801159745"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5056210769","display_name":"Gaurav Goyal","orcid":"https://orcid.org/0000-0001-6148-5177","observed_orcids":["https://orcid.org/0000-0001-6148-5177"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]},{"id":"https://openalex.org/I4390039250","display_name":"UAB Medicine","ror":"https://ror.org/036554539","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039250"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gaurav Goyal","raw_affiliation_strings":["6Division of Hematology/Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6Division of Hematology/Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL","institution_ids":["https://openalex.org/I32389192","https://openalex.org/I4390039250"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2500,"currency":"USD","value_usd":2500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.19578794,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"140","issue":"Supplement 1","first_page":"1076","last_page":"1078"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10685","display_name":"Viral-associated cancers and disorders","score":0.9814000129699707,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10685","display_name":"Viral-associated cancers and disorders","score":0.9814000129699707,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.004999999888241291,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11655","display_name":"HIV-related health complications and treatments","score":0.00419999985024333,"subfield":{"id":"https://openalex.org/subfields/2711","display_name":"Emergency Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/diffuse-large-b-cell-lymphoma","display_name":"diffuse large B-cell lymphoma","score":0.9779999852180481},{"id":"https://openalex.org/keywords/hiv","display_name":"HIV","score":0.3799999952316284},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.6579999923706055},{"id":"https://openalex.org/keywords/survival-disparities","display_name":"survival disparities","score":0.8840000033378601},{"id":"https://openalex.org/keywords/antiretroviral-therapy","display_name":"antiretroviral therapy","score":0.8669999837875366},{"id":"https://openalex.org/keywords/integrase-inhibitors","display_name":"integrase inhibitors","score":0.9879999756813049},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.7229999899864197},{"id":"https://openalex.org/keywords/aids-defining-malignancies","display_name":"AIDS-defining malignancies","score":0.7599999904632568},{"id":"https://openalex.org/keywords/racial-disparities","display_name":"racial disparities","score":0.41499999165534973},{"id":"https://openalex.org/keywords/black-patients","display_name":"Black patients","score":0.5809999704360962},{"id":"https://openalex.org/keywords/hispanic-patients","display_name":"Hispanic patients","score":0.6800000071525574},{"id":"https://openalex.org/keywords/age-at-diagnosis","display_name":"age at diagnosis","score":0.4129999876022339},{"id":"https://openalex.org/keywords/landmark-analysis","display_name":"landmark analysis","score":0.38600000739097595},{"id":"https://openalex.org/keywords/immortal-time-bias","display_name":"immortal time bias","score":0.7699999809265137},{"id":"https://openalex.org/keywords/national-cancer-database","display_name":"National Cancer Database","score":0.6520000100135803},{"id":"https://openalex.org/keywords/propensity-score-matching","display_name":"propensity score matching","score":0.5839999914169312}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8217779397964478},{"id":"https://openalex.org/C2778559949","wikidata":"https://www.wikidata.org/wiki/Q2626074","display_name":"Diffuse large B-cell lymphoma","level":3,"score":0.7063079476356506},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6304712295532227},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5076500177383423},{"id":"https://openalex.org/C17923572","wikidata":"https://www.wikidata.org/wiki/Q7250160","display_name":"Propensity score matching","level":2,"score":0.4858705401420593},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.46921244263648987},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.43639075756073},{"id":"https://openalex.org/C2778336483","wikidata":"https://www.wikidata.org/wiki/Q5090632","display_name":"Chemotherapy regimen","level":3,"score":0.4255637526512146},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.34587860107421875}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2022-169930","doi":"https://doi.org/10.1182/blood-2022-169930","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2022-169930","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0},{"id":"https://metadata.un.org/sdg/10","display_name":"Reduced inequalities","score":0.5676000118255615}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4389243382","https://openalex.org/W4417019015","https://openalex.org/W4403986954","https://openalex.org/W2755661484","https://openalex.org/W4386306013","https://openalex.org/W4417001923","https://openalex.org/W2592087354","https://openalex.org/W3096239751","https://openalex.org/W2622286709","https://openalex.org/W3155025855"],"abstract_inverted_index":{"Background":[0],"Diffuse":[1],"large":[2],"B-cell":[3],"lymphoma":[4,57],"(DLBCL)":[5],"is":[6,658,677],"the":[7,81,234,306,421,523,582,618,628,647,671,681],"most":[8],"frequent":[9],"AIDS":[10],"defining":[11],"malignancy":[12],"in":[13,83,197,305,585,670],"people":[14,516],"with":[15,105,112,164,180,214,233,248,360,382,395,455,480,517,569,642],"HIV":[16,40,114,419,504],"(PWH).":[17],"Historically,":[18],"HIV-positive":[19],"(HIV+)":[20],"DLBCL":[21,31,93,106,225,341,384,426,518,547,571,625,644],"patients":[22,213,641,650],"(pts)":[23],"had":[24,385,450],"poor":[25],"outcomes":[26,87,415,626],"compared":[27,90,464,568],"to":[28,35,75,91,102,148,169,201,245,298,316,334,377,418,465,482,550,621,649,679,684],"HIV-negative":[29],"(HIV-)":[30],"pts,":[32,380],"largely":[33],"due":[34],"aggressive":[36],"disease":[37,287],"and":[38,53,58,135,142,175,190,284,313,405,494,561,591,667],"suboptimal":[39],"therapies.":[41],"More":[42],"recently,":[43],"novel":[44,631,672],"combined":[45],"anti-retroviral":[46],"therapies":[47],"(ART)":[48],"have":[49,279,335,551],"allowed":[50],"for":[51,88,152,182,209,339,356,424,515],"safe":[52],"concurrent":[54],"management":[55],"of":[56,167,220,251,267,351,460,510,513,630,662],"HIV.":[59],"However,":[60],"limited":[61],"data":[62,634],"exists":[63],"on":[64,77,124,519],"how":[65],"this":[66,693],"progress":[67],"has":[68],"affected":[69],"survival":[70,85,637],"over":[71],"time.":[72],"We":[73,616],"aimed":[74],"evaluate,":[76],"a":[78,198,207,347,507,659],"national":[79],"level,":[80],"trends":[82],"overall":[84,457],"(OS)":[86],"HIV+":[89,168,230,240,293,328,375,383,425,448,546,590],"HIV-":[92,170,236,378,466,570,592],"pts.":[94,171,572],"Methods":[95],"The":[96],"National":[97],"Cancer":[98],"Database":[99],"was":[100,161,195,363],"used":[101],"identify":[103],"pts":[104,111,153,226,237,241,294,329,358,427,449,467,548,593],"diagnosed":[107],"from":[108,127],"2004-2018.":[109],"Only":[110],"reported":[113],"status":[115],"were":[116,121,146,178,229,242,295,330,541],"included.":[117],"Diagnostic":[118],"years":[119],"(yrs)":[120],"grouped":[122],"based":[123],"ART":[125,673],"availability":[126],"2004-2007":[128],"(three":[129],"drug":[130],"therapy),":[131],"2008-2012":[132],"(integrase":[133],"inhibitors),":[134],"2013-2018":[136],"(second":[137],"generation":[138,484],"integrase":[139,485],"inhibitors).":[140],"Kaplan-Meier":[141],"Cox":[143,520],"regression":[144,521],"analyses":[145],"performed":[147,163,179],"compare":[149],"OS":[150,355,389,407,423,563,587,603],"only":[151],"who":[154,540,651],"received":[155],"multiagent":[156,361],"chemotherapy.":[157],"Propensity":[158,172],"score":[159,173],"matching":[160,166,174],"then":[162],"1:1":[165],"multivariate":[176],"analysis":[177,194,537,648],"adjustment":[181],"age,":[183],"stage,":[184],"sex,":[185],"race,":[186],"ethnicity,":[187],"median":[188,249,348,354,388,422,434,438,442],"income,":[189],"insurance":[191],"status.":[192],"Survival":[193],"repeated":[196],"landmarked":[199],"cohort":[200],"limit":[202],"immortal":[203],"time":[204,475,525],"bias":[205],"as":[206,567,687,689],"surrogate":[208],"early":[210,453,663,686],"death,":[211],"excluding":[212],"death":[215,454,514],"or":[216,273],"last-contact":[217],"within":[218,576],"6-months":[219],"diagnosis.":[221],"Results":[222],"Of":[223],"146,249":[224],"identified,":[227],"6%":[228],"(N=9,373).":[231],"Compared":[232],"136,876":[235],"at":[238,319,543,653],"diagnosis,":[239],"more":[243,296,314,332],"likely":[244,297,315,333],"be":[246,299],"younger":[247],"age":[250],"47":[252],"yrs":[253,260,365],"(interquartile":[254],"range":[255],"[IQR]":[256],"40-55)":[257],"vs.":[258,265,271,277,282,289,302,311,323,343,391,399,403,409,462,492,497,555,559,565,598,605,612],"68":[259],"(IQR":[261],"57-77),":[262],"male":[263],"(78%":[264],"54%),":[266],"Black":[268],"race":[269],"(37%":[270],"7%)":[272],"Hispanic":[274],"ethnicity":[275],"(17%":[276],"7%),":[278],"B-symptoms":[280],"(51%":[281],"30%)":[283],"stage":[285],"IV":[286],"(48%":[288],"37%)":[290],"(all":[291,325,411,445],"p<0.001).":[292,326,345,412,446,534,614],"uninsured":[300],"(12%":[301],"4%),":[303],"reside":[304],"lowest":[307],"income":[308],"areas":[309],"(32%":[310],"16%),":[312],"receive":[317],"treatment":[318,338],"academic":[320],"centers":[321],"(52%":[322],"38%)":[324],"Furthermore,":[327,447],"significantly":[331,386,451],"no":[336],"documented":[337],"their":[340],"(23%":[342],"17%,":[344],"With":[346],"follow":[349],"up":[350],"3.5":[352],"yrs,":[353,436,440],"all":[357],"treated":[359],"chemotherapy":[362],"8.8":[364],"(95%":[366],"CI":[367,532],"8.6-8.9":[368],"yrs).":[369],"On":[370,535],"propensity":[371],"matched":[372],"analysis,":[373],"comparing":[374],"(N=5,112)":[376,379],"those":[381,539],"worse":[387],"(6.7":[390],"12.5":[392],"yrs),":[393],"along":[394],"shorter":[396,552],"1-year":[397,553],"(69%":[398],"82%%),":[400],"3-year":[401,557],"(57%":[402],"71%%),":[404],"5-year":[406,562,586,595,602,609],"(53%":[408],"67%)":[410],"When":[413],"examining":[414],"by":[416],"access":[417,481],"therapies,":[420],"improved":[428,478],"throughout":[429,522],"each":[430,473,577],"successive":[431,474,578],"period":[432,526],"(2004-2007:":[433,487,594],"4.0":[435],"2008-2012:":[437,490,601],"5.9":[439],"2013-2018:":[441,495,608],"not":[443],"reached)":[444],"increased":[452,511],"an":[456],"6-month":[458],"mortality":[459,664,683,691],"18%":[461],"10%":[463],"(p<0.001).":[468,499],"This":[469,573],"trend":[470,574],"persisted":[471],"through":[472,627],"period,":[476,580],"but":[477],"slightly":[479],"second":[483],"inhibitors":[486],"20%":[488,491],"vs.11%,":[489],"6%,":[493],"15%":[496],"6%)":[498],"Overall,":[500],"we":[501],"found":[502],"that":[503,636],"infection":[505],"remained":[506,575],"significant":[508],"predictor":[509],"risk":[512,661],"entire":[524],"(hazard":[527],"ratio":[528],"[HR]":[529],"1.56,":[530],"95%":[531],"1.46-1.70,":[533],"landmark":[536],"among":[538,640,665,692],"alive":[542],"6":[544,655],"months,":[545],"continued":[549],"(85%":[554],"91%),":[556],"(70%":[558],"77%),":[560],"(64%":[564],"70%)":[566],"diagnostic":[579],"though":[581],"absolute":[583],"difference":[584],"shortened":[588],"between":[589],"OS,":[596,610],"59%":[597],"69%,":[599],"p<0.001,":[600],"70%":[604],"76%,":[606],"p<0.01,":[607],"74%":[611],"78%,":[613],"Conclusions":[615],"present":[617],"largest":[619],"study":[620],"date":[622],"evaluating":[623],"HIV-associated":[624,643],"era":[629],"ART.":[632],"These":[633],"highlight":[635],"disparities":[638],"persist":[639],"despite":[645],"limiting":[646],"survive":[652],"least":[654],"months.":[656],"There":[657],"high":[660],"PWH":[666],"DLBCL,":[668],"even":[669],"era.":[674],"Further":[675],"research":[676],"necessary":[678],"delineate":[680],"cause-specific":[682],"mitigate":[685],"well":[688],"late":[690],"vulnerable":[694],"population.":[695],"Figure":[696],"1View":[697,700],"largeDownload":[698,701],"PPTFigure":[699],"PPT":[702],"Close":[703],"modal":[704]},"counts_by_year":[],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2022-11-30T00:00:00"}